Influence of cerebral blood flow on central sleep apnea at high altitude

Sleep

Volumn 37, Issue 10, 2014, Pages 1679-1687

  Burgess, Keith R ^a,b   Lucas, Samuel J E ^c   Shepherd, Kelly ^a   Dawson, Andrew ^a   Swart, Marianne ^a   Thomas, Kate N ^c   Lucas, Rebekah A I ^c   Donnelly, Joseph ^c   Peebles, Karen C ^c   Basnyat, Rishi ^d,e   Ainslie, Philip N ^f  

^a Peninsula Sleep Laboratory   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d NEPAL INTERNATIONAL CLINIC   (Nepal)

^e BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Central sleep apnea; Cerebral blood flow; Cerebral vascular reactivity; High altitude; Ventilatory responses

Indexed keywords

ACETAZOLAMIDE; CARBON DIOXIDE; INDOMETACIN; CARDIOVASCULAR AGENT;

ADULT; ALTITUDE; APNEA HYPOPNEA INDEX; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CENTRAL SLEEP APNEA SYNDROME; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOXIA; MALE; POLYSOMNOGRAPHY; PRESSURE; RANDOMIZED CONTROLLED TRIAL; REBREATHING; ACCLIMATIZATION; ANOXIA; BLOOD; BRAIN CIRCULATION; DRUG EFFECTS; HYPERCAPNIA; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SINGLE BLIND PROCEDURE; WAKEFULNESS; YOUNG ADULT;

ACCLIMATIZATION; ACETAZOLAMIDE; ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; ALTITUDE; ANOXIA; CARBON DIOXIDE; CARDIOVASCULAR AGENTS; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; HYPERCAPNIA; INDOMETHACIN; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SINGLE-BLIND METHOD; SLEEP APNEA, CENTRAL; WAKEFULNESS; YOUNG ADULT;

EID: 84907932204     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4080     Document Type: Article

References (50)

1. Krum H, Jelinek M, Stewart S, Sindone A, Atherton J, Hawkes A. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia. Med J Aust 2006;185:549-56.
2. Hanly P, Millar T, Steljes D, Baert R, Frais M, Jryger M. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989;111:777-82.
3. Bradley T, Logan A, Kimoff R, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-33.
4. De Backer W, Verbraecken J, Willeman M, Wittesaele W, De Cock W, Van De Heyning P. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 1995;151:87-91.
5. Swenson E, Hughes J. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol 1993;74:230-7.
6. Berssenbrugge A, Dempsey J, Iber C, Skatrud J, Wilson P. Mechanisms of hypoxia induced periodic breathing during sleep in humans. J Physiol 1983;343:507-25.
7. Mebrate Y, Wilson K, Manisty C, et al. Dynamic CO2 therapy in periodic breathing: a modeling study to deter optimal timing and dosage regimes. J Appl Physiol 2009;107:696-706.
8. Burgess K, Johnson P, Edwards N. Central and obstructive sleep apnea during ascent to high altitude. Respirology 2004;9:222-9.
9. Dempsey J, Skatrud J. A sleep-induced apneic threshold and its consequences. Am Rev Respir Dis 1986;133:1163-70.
10. Dempsey J. Crossing the apneic threshold: causes and consequences. Exp Physiol 2005;90:13-24.
11. White D. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005;172:1363-70.
12. Xie A, Skatrud J, Morgan B, et al. Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy humans. J Physiol 2006;577:319-29.
13. Lucas S, Burgess K, Thomas K, et al. Alterations in cerebral blood flow and cerebrovascular reactivity during 14 days at 5050m. J Physiol 2011;589:741-53.
14. Burgess K, Burgess K, Subedi P, Ainslie P, Topor Z, Whitelaw W. Prediction of periodic breathing at altitude. Adv Exp Med Biol 2008;605:442-6.
15. Andrews G, Ainslie P, Shepherd K, et al. The effect of partial acclimatization to high altitude on loop gain and central sleep apnea severity. Respirology 2012;17:835-40.
16. Douglas N, White D, Weil J, Pickett C, Zwillich C. Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis 1982;126:758-62.
17. Fan J-L, Burgess K, Thomas K, et al. Effects of acetazolamide on cerebrovascular function and breathing stability at 5,050m. J Physiol 2012;590(Pt 5):1213-25.
18. Fan J-L, Burgess K, Thomas K, et al. Influence of indomethacin on ventilatory and cerebrovascular responsiveness to CO2 and breathing stability: the influence of PCO2 gradients. Am J Physiol Regul Integr Comp Physiol 2010;298:R1648-58.
19. Basnyat B, Gertsch J, Holck P, et al. Acetazolamide 125 mg BD is not significantly differeent from 375 mg BD in the prevention of acute mountain sickness: the Prophylactic Acetazolamide dosage Comparison for Efficacy (PACE) trial. High Alt Med Biol 2006;7:17-27.
20. Ritschel W, Paulos C, Arancibia A, Agrawal M, Wetzelsberger K, Lucker P. Pharmacokinetics of acetazolamide in healthy volunteers after shortand long-term exposure to high altitude. J Clin Pharmacol 1998;38:533-9.
21. Xie A, Skatrud J, Khayat R, Dempsey J, Morgan B, Russell D. Cerebrovascular response to carbon dioxide in patients with congestive heart failure. Am J Respir Crit Care Med 2005;172:371-8.
22. Burgess K, Johnson P, Edwards N, Cooper J. Acute mountain sickness is associated with sleep desaturation at high altitude. Respirology 2004;9:485-92.
23. Sleep-related breathing disorder in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep 1999;22:667-89.
24. Rechtschaffen A, Kales A. A manual of standardised terminology, techniques and scoring stages of human subjects. Brain Information Service/Brain Research Institute, University of California. Los Angeles, CA, 1990.
25. Duffin J. Measuring the respiratory chemoreflexes in humans. Respir Physiol Neurobiol 2011;177:71-9.
26. Duffin J, Mohan R, Vasiliou P, Stephenson R, Mahamed S. A model of the chemoreflex control of breathing in humans: model parameters measurement. Respir Physiol 2000;120:13-26.
27. Cunningham D, Hey E, Patrick J, Lloyd B. The effect of noradrenaline infusion on the relation between pulmonary ventilation and the alveloar PO2 and PCO2 in man. Ann N Y Acad Sci 1963;109:756-71.
28. Rebuck A, Campbell E. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis 1974;109:345-50.
29. Robbins P, Zhang S. Letter to the editor. Respir Physiol 1999;115:333.
30. Day T, Wilson R. A negative interaction between brainstem and peripheral respiratory chemoreceptors modulates peripheral chemoreflex magnitude. J Physiol 2009;587:883-96.
31. Duffin J, McEvoy G. The peripheral-chemoreceptor threshold to carbon dioxide in man. J Physiol 1988;406:15-26.
32. Aaslid R, Markwalder T, Nornes H. Noninvasive transcranial doppler, ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982;57:769-74.
33. Moehring M, Spencer M. Power M-Mode Doppler (PMD) for observing cerebral blood flow and tracking emboli. Ultrasound Med Biol 2002;28:49-57.
34. Rosner B. Fundamentals of Biostatistics. Boston, MA: Duxbury Press, 1982.
35. Burgess K, Lucas S, Shepherd K, et al. Worsening of central sleep apnea at high altitude - a role for cerebrovascular function. J Appl Physiol 2013;114:1021-8.
36. Lloyd B, Jukes M, Cunningham D. The relationship between alveolar oxygen pressure and the respiratory response to carbon dioxide in man. Q J Exp Physiol Cogn Med Sci 1958;43:214-22.
37. Lahiri S, Maret K, Sherpa M. Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol 1983;52:281-301.
38. West JB, Peters RM Jr, Aksnes G, Maret KH, Milledge JS, Schoene RB. Nocturnal periodic breathing at altitudes of 6,300 and 8,050 m. J Appl Physiol 1986;61:280-7.
39. Masuyama S, Kohchiyama S, Shinozaki T, et al. Periodic breathing at high altitude and ventilatory responses to O2 and CO2. Jpn J Physiol 1989;39:523-35.
40. Hackett P, Roach R, Harrison G, Schoene R, Mills WJ. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis 1987;135:896-8.
41. Vovk A, Duffin J, Kowalchuk J, Paterson D, Cunningham D. Changes in chemoreflex characteristics following acute carbonic anhydrase inhibition in humans at rest. Exp Physiol 2000;85:847-56.
42. Bloch K, Latshang T, Turk A, et al. Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546m). Am J Respir Crit CareMed 2010;182:562-8.
43. Salvaggio A, Insalaco G, Marrone O, et al. Effects of high-altitude periodic breathing on sleep and arterial oxyhaemoglobin saturation. Eur Respir J 1996;12:408-13.
44. Lombardi C, Meriggi P, Agostino P, et al. High-altitude hypoxia and periodic breathing during sleep: gender-related differences. J Sleep Res 2013;22:322-30.
45. Teppema L, Dahan A. The ventilatory response to hypoxia in mammals: mechanism, measurement, and analysis. Physiol Rev 2010;90:675-754.
46. Powell FL. Measuring the respiratory chemoreflexes in humans by J. Duffin. Respir Physiol Neurobiol 2012;181:44-5.
47. Mahutte C, Rebuck A. Influence of rate of induction of hypoxia on the ventilatory response. J Physiol 1977;284:219-27.
48. Van Klaveren R, Demedts M. Response to letter to editor. Respir Physiol 1999;115:335.
49. van Klaveren R, Demedts M. Determinants of the hypercapnic and hypoxic response in normal man. Respir Physiol 1998;113:157-65.
50. Steinback C, Poulin M. Cardiovascular and cerebrovascular responses to acute isocapnic and poikilocapnic hyposic in humans. J Appl Physiol 2008;104:482-9.